2-(1,5-Dimethyl-1h-pyrazol-4-yl)acetonitrile, 97%, 250mg

3-Iodo-L-tyrosine>98.0%(T)5g

(3R,4R)-tert-Butyl 4-(aminomethyl)-3-hydroxypiperidine-1-carboxylate, 95.0%, 250mg

Diisobutylene (mixture of isomers) (stabilized with BHT)>94.0%(GC)25mL

(6-Fluoropyridin-2-yl)methanamine hydrochloride, 95+%, 2.5g

(3R,4S,5S)-tert-Butyl 3-methoxy-5-methyl-4-(methylamino)heptanoate hydrochloride, 95.0%, 5g

(4S,4'S)-2,2'-(Cycloheptane-1,1-diyl)bis(4-phenyl-4,5-dihydrooxazole), 97%, 1g

(S)-5-Methoxy-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride, 95%, 25g

2,3,6-Trimethylquinoxaline, 95.0%, 5g

6-Bromo-2-chloro-3-methylpyridine, 98%, 1g

3-[2-(2-Ethoxycarbonyl-ethoxy)-ethoxy]-propionic acid, 97.0%, 250mg

4'-methyl-2-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

1-Benzyl-3-cyano-pyrrolidine, 97.0%, 1g